Bionano Genomics (BNGO) Operating Expenses (2017 - 2026)

Bionano Genomics' Operating Expenses history runs 10 years deep, the most recent figure standing at $11.1 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 2.23% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $46.3 million (down 43.45% YoY), while the FY2025 annual figure was $46.5 million, down 55.42% from the prior year.
• Operating Expenses came in at $11.1 million for Q1 2026 at Bionano Genomics, down from $11.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $116.0 million in Q3 2023 to a low of $11.1 million in Q1 2026.
• A 5-year average of $30.9 million and a median of $30.8 million in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 241.48% in 2023 and slumped 69.43% in 2024, its largest moves.
• Bionano Genomics' Operating Expenses stood at $39.3 million in 2022, then tumbled by 30.36% to $27.4 million in 2023, then plunged by 43.93% to $15.4 million in 2024, then declined by 22.29% to $11.9 million in 2025, then slipped by 6.59% to $11.1 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $11.1 million, $11.9 million, and $11.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison